Cash and Cash Equivalents, at Carrying Value in USD of Propanc Biopharma, Inc. from Q2 2011 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Summary
Propanc Biopharma, Inc. quarterly Cash and Cash Equivalents, at Carrying Value history and change rate from Q2 2011 to Q1 2023.
  • Propanc Biopharma, Inc. Cash and Cash Equivalents, at Carrying Value for the quarter ending 31 Mar 2023 was $93.2K, a 30.4% decline year-over-year.
Cash and Cash Equivalents, at Carrying Value, Quarterly (USD)
Cash and Cash Equivalents, at Carrying Value, YoY Quarterly Change (%)

Propanc Biopharma, Inc. Quarterly Cash and Cash Equivalents, at Carrying Value (USD)

Period Value YoY Chg Change % Date Report Filed
Q1 2023 $93.2K -$40.6K -30.4% 31 Mar 2023 10-Q 15 May 2023
Q4 2022 $24.5K -$49.1K -66.8% 31 Dec 2022 10-Q 10 Feb 2023
Q3 2022 $19.4K -$26.4K -57.7% 30 Sep 2022 10-Q 14 Nov 2022
Q2 2022 $4.07K +$1.81K +80.4% 30 Jun 2022 10-Q 15 May 2023
Q1 2022 $134K +$119K +827% 31 Mar 2022 10-Q 16 May 2022
Q4 2021 $73.6K 31 Dec 2021 10-Q 14 Feb 2022
Q3 2021 $45.8K 30 Sep 2021 10-Q 12 Nov 2021
Q2 2021 $2.26K -$64.8K -96.6% 30 Jun 2021 10-K 28 Sep 2022
Q1 2021 $14.4K 31 Mar 2021 10-Q 14 May 2021
Q2 2020 $67K 30 Jun 2020 10-K 28 Sep 2021
Q4 2014 $14.6K +$13.9K +1882% 31 Dec 2014 10-Q 17 Feb 2015
Q3 2014 $4.51K -$32.6K -87.8% 30 Sep 2014 10-Q 19 Nov 2014
Q2 2014 $87.8K +$87.8K 30 Jun 2014 10-Q 17 Feb 2015
Q1 2014 $40.00 31 Mar 2014 10-Q 20 May 2014
Q4 2013 $736 +$242 +49% 31 Dec 2013 10-Q 17 Feb 2015
Q3 2013 $37.1K +$36K +3361% 30 Sep 2013 10-Q 19 Nov 2014
Q2 2013 $0 -$179 -100% 30 Jun 2013 10-Q 17 Feb 2015
Q4 2012 $494 -$39.2K -98.8% 31 Dec 2012 10-Q 14 Feb 2014
Q3 2012 $1.07K -$11K -91.1% 30 Sep 2012 10-Q 14 Nov 2013
Q2 2012 $179 +$47.00 +35.6% 30 Jun 2012 10-K 14 Oct 2014
Q1 2012 $39.5K 31 Mar 2012 10-Q 20 May 2013
Q4 2011 $39.7K 31 Dec 2011 10-Q 20 Feb 2013
Q3 2011 $12K 30 Sep 2011 10-Q 19 Nov 2012
Q2 2011 $132 30 Jun 2011 10-K 15 Oct 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.